Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Patel

Showing results (141-150 of 150) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 150 results.
Cancer Research|September 5, 2006
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenograftsAnthony Polverino, Angela Coxon, Charlie Starnes, et al.
Blood|July 10, 2014
PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogeneZhuyan Guo, Anlai Wang, Weidong Zhang, et al.
Echocardiography (Mount Kisco, N.Y.)|July 15, 2006
Usefulness of live/real time three-dimensional transthoracic echocardiography in the identification of individual segment/scallop prolapse of the mitral valveVinod Patel, Ming Chon Hsiung, Navin C Nanda, et al.
The Journal of Biological Chemistry|September 5, 2013
Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approachesQiang Gao, Ingrid Mechin, Nayantara Kothari, et al.
JMIR Cardio|August 15, 2022
Frameworks for Implementation, Uptake, and Use of Cardiometabolic Disease-Related Digital Health Interventions in Ethnic Minority Populations: Scoping ReviewMel Ramasawmy, Lydia Poole, Zareen Thorlu-Bangura, et al.
The Journal of Biological Chemistry|November 14, 2014
Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small moleculeGejing Deng, Junqing Shen, Ming Yin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-SecretaseMatthew R Kaller, Scott S Harried, Brian Albrecht, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2026
Multi-institutional Normal Tissue Complication Probability (NTCP) Prediction Model for Mandibular Osteoradionecrosis: Results from the PREDMORN StudyLaia Humbert-Vidan, Christian R Hansen, Steven Petit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 13, 2025
Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohortsLaia Humbert-Vidan, Serageldin Kamel, Andrew Wentzel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2025
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi StudyAmy C Moreno, Erin E Watson, Laia Humbert-Vidan, et al.
Pageof 15

Showing results (141-150 of 150) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 150 results.
Cancer Research|September 5, 2006
AMG 706, an oral, multikinase inhibitor that selectively targets vascular endothelial growth factor, platelet-derived growth factor, and kit receptors, potently inhibits angiogenesis and induces regression in tumor xenograftsAnthony Polverino, Angela Coxon, Charlie Starnes, et al.
Blood|July 10, 2014
PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogeneZhuyan Guo, Anlai Wang, Weidong Zhang, et al.
Echocardiography (Mount Kisco, N.Y.)|July 15, 2006
Usefulness of live/real time three-dimensional transthoracic echocardiography in the identification of individual segment/scallop prolapse of the mitral valveVinod Patel, Ming Chon Hsiung, Navin C Nanda, et al.
The Journal of Biological Chemistry|September 5, 2013
Evaluation of cancer dependence and druggability of PRP4 kinase using cellular, biochemical, and structural approachesQiang Gao, Ingrid Mechin, Nayantara Kothari, et al.
JMIR Cardio|August 15, 2022
Frameworks for Implementation, Uptake, and Use of Cardiometabolic Disease-Related Digital Health Interventions in Ethnic Minority Populations: Scoping ReviewMel Ramasawmy, Lydia Poole, Zareen Thorlu-Bangura, et al.
The Journal of Biological Chemistry|November 14, 2014
Selective inhibition of mutant isocitrate dehydrogenase 1 (IDH1) via disruption of a metal binding network by an allosteric small moleculeGejing Deng, Junqing Shen, Ming Yin, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
A Potent and Orally Efficacious, Hydroxyethylamine-Based Inhibitor of β-SecretaseMatthew R Kaller, Scott S Harried, Brian Albrecht, et al.
International Journal of Radiation Oncology, Biology, Physics|February 5, 2026
Multi-institutional Normal Tissue Complication Probability (NTCP) Prediction Model for Mandibular Osteoradionecrosis: Results from the PREDMORN StudyLaia Humbert-Vidan, Christian R Hansen, Steven Petit, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 13, 2025
Externally validated digital decision support tool for time-to-osteoradionecrosis risk-stratification using right-censored multi-institutional observational cohortsLaia Humbert-Vidan, Serageldin Kamel, Andrew Wentzel, et al.
International Journal of Radiation Oncology, Biology, Physics|January 18, 2025
International Expert-Based Consensus Definition, Classification Criteria, and Minimum Data Elements for Osteoradionecrosis of the Jaw: An Interdisciplinary Modified Delphi StudyAmy C Moreno, Erin E Watson, Laia Humbert-Vidan, et al.
Pageof 15